FIELD: medicine, pediatrics.
SUBSTANCE: as medicinal preparation it is suggested to apply bifidumbacterin forte. Monotherapy with the preparation mentioned excludes the necessity to apply hormonal preparations and antibiotics at treating infectious mononucleosis in children.
EFFECT: higher efficiency of therapy.
3 ex, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING INFECTIOUS MONONUCLEOSIS IN CHILDREN | 2005 |
|
RU2290200C1 |
METHOD FOR PATHOGENETIC CORRECTION OF METABOLIC DISORDERS IN INFECTIOUS MONONUCLEOSIS CAUSED BY EPSTEIN-BARR VIRUS | 2020 |
|
RU2726070C1 |
METHOD FOR CHRONIC INFECTIOUS MONONUCLEOSIS SEVERITY DETERMINATION IN CHILDREN | 2009 |
|
RU2406433C1 |
METHOD OF YERSINIOSIS INFECTION TREATMENT FOR CHILDREN | 2007 |
|
RU2371174C2 |
METHOD OF FORECASTING SERIOUSNESS OF INFECTIOUS MONONUCLEOSIS OF VARIOUS ETIOLOGY AT CHILDREN | 2008 |
|
RU2360255C1 |
METHOD FOR ASSESSING DEGREE OF INFECTIOUS MONONUCLEOSIS IN CHILDREN | 2017 |
|
RU2673073C1 |
METHOD FOR DETERMINING AETIOLOGY OF TONSILLITIS IN CHILDREN | 2012 |
|
RU2494398C1 |
METHOD FOR PREDICTING THE FLOW OF INFECTIOUS MONONUCLEOSIS CAUSED WITH EPSTEIN-BARR VIRUS IN CHILDREN | 2005 |
|
RU2285262C1 |
METHOD OF DIFFERENTIAL DIAGNOSTICS OF INFECTIOUS MONONUCLEOSIS OF VARIOUS ETIOLOGY AT CHILDREN | 2008 |
|
RU2360254C1 |
METHOD FOR DETERMINATION OF SEVERITY OF INFECTIOUS MONONUCLEOSIS CAUSED BY EPSTEIN - BARR VIRUS IN ADULTS | 2017 |
|
RU2639596C1 |
Authors
Dates
2004-12-27—Published
2003-06-04—Filed